Planet 13 Launches Dreamland Cannabis Chocolate in Florida
Commercial cannabis edible launches such as Planet 13's Dreamland chocolate influence patient dosing precision and clinical outcomes. Understanding these products' formulation and pharmacokinetics helps clinicians guide patients safely. This update…
Singaporean Man Executed for Cannabis Trafficking: Clinical Insights
The Singapore cannabis execution case underscores severe legal risks for medical cannabis patients. Singapore enforces a strict death penalty for cannabis trafficking despite global legalization trends. Clinicians must understand international cannabis…
3 US Senators Propose State Opt-Out for Hemp Product Ban
The hemp product ban is facing new challenges as three US senators propose allowing states to opt out of federal restrictions. This change could create a patchwork of state regulations for intoxicating hemp products. Clinicians must be aware of these…
Life in Prison for a First-Time, Nonviolent Cannabis Charge? SSDP Highlights Barriers
Extreme cannabis sentencing barriers create profound challenges for patients with nonviolent cannabis charges. These legal consequences restrict access to healthcare, employment, and housing. Understanding these barriers is critical for clinicians and…
High-Risk Behavior? What Your Patients Should Know About Cannabis and Diabetes
Cannabis and diabetes management require careful attention to glucose control and patient safety. Understanding how cannabinoids affect insulin sensitivity is essential. Patients should monitor blood sugar closely when using cannabis.
New to THC? Why Low-Dose Cannabis Formulations Matter for Beginners
Low-dose cannabis formulations address a critical clinical need for cannabis-naive patients. These products enable safer THC initiation by reducing adverse effects from standard dosing. Standardized low-dose cannabis formulations allow precise titration…
CBD Gummies Hallucinations: What the Evidence Actually Shows
Reports of hallucinations linked to CBD products highlight the importance of CBD product safety adverse events. These events often stem from contamination or dosing errors rather than CBD itself. Understanding these risks is crucial for patient safety…
Bring It On: Meet the Cannabis CMO Welcoming Scrutiny With Open Arms
The cannabis clinical scrutiny embraced by industry leaders marks a pivotal shift toward transparency and patient safety. This approach ensures clinicians have reliable data for evidence-based prescribing decisions. Cannabis clinical scrutiny benefits…
Are CBD Gummies Good for Pain? A Practical Look at the Evidence and Real-World Use
CBD gummies pain management evidence is limited but growing as patients increasingly use these products for pain relief. This article reviews the clinical data and practical considerations. Understanding cbd gummies pain management evidence helps…
Understanding the 50mg CBD Gummies Effect and Dosing
The 50mg CBD dosing guidelines provide important insights into the effects of this moderate-to-high dose in gummy form. Understanding these guidelines helps clinicians advise patients on safe and effective use. Individual responses vary, making…